JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collins, S. J.
Right arrow Articles by Maraganore, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collins, S. J.
Right arrow Articles by Maraganore, D. M.

Journal of Neurology, Neurosurgery, and Psychiatry, 1995, Vol 58, 167-173


PAPERS

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria

SJ Collins, JE Ahlskog, JE Parisi and DM Maraganore
Department of Neurology, Mayo Clinic, Rochester, MN 55905.

All cases examined postmortem at the Mayo Clinic that met the classic neuropathological criteria for progressive supranuclear palsy (PSP) were identified for retrospective clinical analyses. The necropsy material was re-examined by a second neuropathologist to confirm the pathological diagnosis of PSP, yielding 12 cases. A range of clinical signs were documented in these patients, with numerous findings beyond those noted in the original descriptions of this disorder. Atypical clinical findings included absence of supranuclear gaze palsy (two cases), prominent asymmetry (two), arm dystonia (two), upper limb apraxia (two), myoclonus (two), chorea (one), eyelid opening apraxia (one), and respiratory disturbance (one). A definite clinical diagnosis of PSP had been made during life in only eight of the 12 patients. From the retrospective analysis of these 12 cases, a set of clinical criteria were developed for the premortem diagnosis of PSP emphasising differences from other akinetic-rigid disorders.


© 1995 by Journal of Neurology, Neurosurgery, and Psychiatry



This article has been cited by other articles:


Home page
BrainHome page
Z. Ahmed, K. A. Josephs, J. Gonzalez, A. DelleDonne, and D. W. Dickson
Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy
Brain, February 1, 2008; 131(2): 460 - 472.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Padovani, B Borroni, S M Brambati, C Agosti, M Broli, R Alonso, P Scifo, G Bellelli, A Alberici, R Gasparotti, et al.
Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy
J. Neurol. Neurosurg. Psychiatry, April 1, 2006; 77(4): 457 - 463.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. Mokri, J. E. Ahlskog, J. R. Fulgham, and J. Y. Matsumoto
Syndrome resembling PSP after surgical repair of ascending aorta dissection or aneurysm
Neurology, March 23, 2004; 62(6): 971 - 973.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
U. Nath, Y. Ben-Shlomo, R.G. Thomson, A.J. Lees, and D.J. Burn
Clinical features and natural history of progressive supranuclear palsy: A clinical cohort study
Neurology, March 25, 2003; 60(6): 910 - 916.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
K. A. Josephs, T. Ishizawa, Y. Tsuboi, N. Cookson, and D. W. Dickson
A Clinicopathological Study of Vascular Progressive Supranuclear Palsy: A Multi-infarct Disorder Presenting as Progressive Supranuclear Palsy
Arch Neurol, October 1, 2002; 59(10): 1597 - 1601.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Bhidayasiri, D.E. Riley, J.T. Somers, A.J. Lerner, J.A. Buttner-Ennever, and R.J. Leigh
Pathophysiology of slow vertical saccades in progressive supranuclear palsy
Neurology, December 11, 2001; 57(11): 2070 - 2077.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
U. Nath, Y. Ben-Shlomo, R. G. Thomson, H. R. Morris, N. W. Wood, A. J. Lees, and D. J. Burn
The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK
Brain, July 1, 2001; 124(7): 1438 - 1449.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Gwinn-Hardy, J. Y. Chen, H.-C. Liu, T. Y. Liu, M. Boss, W. Seltzer, A. Adam, A. Singleton, W. Koroshetz, C. Waters, et al.
Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese
Neurology, September 26, 2000; 55(6): 800 - 805.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. Kimber, C. J. Mathias, A. J. Lees, K. Bleasdale-Barr, H. S. Chang, A. Churchyard, and L. Watson
Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy
Brain, July 1, 2000; 123(7): 1422 - 1430.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Rojo, R. S. Pernaute, A. Fontan, P. G. Ruiz, J. Honnorat, T. Lynch, S. Chin, I. Gonzalo, A. Rabano, A. Martinez, et al.
Clinical genetics of familial progressive supranuclear palsy
Brain, July 1, 1999; 122(7): 1233 - 1245.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. H. Bower, D. M. Maraganore, S. K. McDonnell, and W. A. Rocca
Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990
Neurology, April 1, 1999; 52(6): 1214 - 1214.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
D. J. Gelb, E. Oliver, and S. Gilman
Diagnostic Criteria for Parkinson Disease
Arch Neurol, January 1, 1999; 56(1): 33 - 39.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M. Asahina, T. Suhara, H. Shinotoh, O. Inoue, K. Suzuki, and T. Hattori
Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study
J. Neurol. Neurosurg. Psychiatry, August 1, 1998; 65(2): 155 - 163.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
K. Kompoliti, C. G. Goetz, I. Litvan, K. Jellinger, and M. Verny
Pharmacological Therapy in Progressive Supranuclear Palsy
Arch Neurol, August 1, 1998; 55(8): 1099 - 1102.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
R. Oliva, E. Tolosa, M. Ezquerra, J. L. Molinuevo, F. Valldeoriola, J. Burguera, M. Calopa, M. Villa, and F. Ballesta
Significant Changes in the Tau A0 and A3 Alleles in Progressive Supranuclear Palsy and Improved Genotyping by Silver Detection
Arch Neurol, August 1, 1998; 55(8): 1122 - 1124.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
I. Litvan, A. MacIntyre, C. G. Goetz, G. K. Wenning, K. Jellinger, M. Verny, J. J. Bartko, J. Jankovic, A. McKee, J. P. Brandel, et al.
Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies: A Clinicopathologic Study
Arch Neurol, July 1, 1998; 55(7): 969 - 978.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1995 by the BMJ Publishing Group Ltd.